Drug Profile
Research programme: eye disorders therapy - HealOr
Alternative Names: HO-0509; HO/05/09Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator HealOr
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Eye-disorders in Israel (Ophthalmic, Drops)
- 14 Jul 2011 Preclinical trials in Eye disorders in Israel (Ophthalmic)